NCT00034814View on ClinicalTrials.gov

Multicenter Trial for Adults With Partial Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Epilepsy
Interventions
DRUG

Talampanel

Non-enzyme-inducing TLP 35mg TID

DRUG

Placebo

Enzyme-inducing placebo TID

DRUG

Talampanel

Enzyme-inducing Talampanel 35 mg TID

DRUG

Talampanel

Enzyme-inducing TLP 50mg TID

DRUG

Placebo

Non-enzyme-inducing placebo TID

DRUG

Talampanel

Non-enzyme-inducing TLP 25mg TID

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00034814 - Multicenter Trial for Adults With Partial Seizures | Biotech Hunter | Biotech Hunter